152 related articles for article (PubMed ID: 32613686)
1. Use of proton pump inhibitors and risk of rosacea: A nationwide population-based study.
Dai YX; Tai YH; Chen CC; Chang YT; Chen TJ; Chen MH
J Dermatol; 2020 Oct; 47(10):1126-1130. PubMed ID: 32613686
[TBL] [Abstract][Full Text] [Related]
2. The Risk of Epilepsy after Long-term Proton Pump Inhibitor Therapy.
Liang CS; Bai YM; Hsu JW; Huang KL; Ko NY; Tsai CK; Yeh TC; Chu HT; Tsai SJ; Chen TJ; Chen MH
Seizure; 2021 Apr; 87():88-93. PubMed ID: 33735722
[TBL] [Abstract][Full Text] [Related]
3. Dose-Dependent Proton Pump Inhibitor Exposure and Risk of Type 2 Diabetes: A Nationwide Nested Case-Control Study.
Kuo HY; Liang CS; Tsai SJ; Chen TJ; Chu CS; Chen MH
Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886592
[TBL] [Abstract][Full Text] [Related]
4. Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study.
Wang WT; Li CY; Chang YT; Bai YM; Tsai SJ; Chen TJ; Chiou SH; Chen MH
Allergy Asthma Proc; 2023 Sep; 44(5):345-353. PubMed ID: 37641222
[No Abstract] [Full Text] [Related]
5. Association Between Acid-Suppressive Drugs and Risk of Rosacea: Retrospective Study Using the Korean National Health Insurance Service-National Sample Cohort.
Kim JH; Min JH; Jo YW; Kwon JW; Her Y
J Korean Med Sci; 2023 Dec; 38(47):e402. PubMed ID: 38050914
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitors and risk of periampullary cancers--A nested case-control study.
Chien LN; Huang YJ; Shao YH; Chang CJ; Chuang MT; Chiou HY; Yen Y
Int J Cancer; 2016 Mar; 138(6):1401-9. PubMed ID: 26488896
[TBL] [Abstract][Full Text] [Related]
7. Proton Pump Inhibitors Are Associated with Increased Risk of Psoriasis: A Nationwide Nested Case-Control Study.
Li CY; Dai YX; Chang YT; Bai YM; Tsai SJ; Chen TJ; Chen MH
Dermatology; 2021; 237(6):884-890. PubMed ID: 34474411
[TBL] [Abstract][Full Text] [Related]
8. Risk of systemic autoimmune diseases in gastric disease patients with proton pump inhibitor use: a nationwide cohort study in Taiwan.
Chen HY; Lin JJ; Yang B; Lin MC
Clin Rheumatol; 2020 Sep; 39(9):2773-2780. PubMed ID: 32152918
[TBL] [Abstract][Full Text] [Related]
9. Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.
Wang YF; Chen YT; Luo JC; Chen TJ; Wu JC; Wang SJ
Am J Gastroenterol; 2017 Jul; 112(7):1084-1093. PubMed ID: 28397874
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitor-related headaches: a nationwide population-based case-crossover study in Taiwan.
Liang JF; Chen YT; Fuh JL; Li SY; Chen TJ; Tang CH; Wang SJ
Cephalalgia; 2015 Mar; 35(3):203-10. PubMed ID: 24853165
[TBL] [Abstract][Full Text] [Related]
11. Proton Pump Inhibitor Exposure and Acute Myocardial Infarction Risk: A Nested Cohort Study.
Tseng HJ; Cheng CM; Tsai SJ; Lin WC; Bai YM; Tsai CF; Su TP; Li CT; Chen TJ; Chen MH
Cardiovasc Toxicol; 2021 Jun; 21(6):444-450. PubMed ID: 33625647
[TBL] [Abstract][Full Text] [Related]
12. Association between proton pump inhibitors and the risk of hepatocellular carcinoma.
Shao YJ; Chan TS; Tsai K; Wu SY
Aliment Pharmacol Ther; 2018 Aug; 48(4):460-468. PubMed ID: 29897132
[TBL] [Abstract][Full Text] [Related]
13. Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.
Tai SY; Chien CY; Wu DC; Lin KD; Ho BL; Chang YH; Chang YP
PLoS One; 2017; 12(2):e0171006. PubMed ID: 28199356
[TBL] [Abstract][Full Text] [Related]
14. Negative Association of Proton Pump Inhibitors With Subsequent Development of Breast Cancer: A Nationwide Population-Based Study.
Chen CH; Lee CZ; Lin YC; Kao LT; Lin HC
J Clin Pharmacol; 2019 Mar; 59(3):350-355. PubMed ID: 30329162
[TBL] [Abstract][Full Text] [Related]
15. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
Tsai CF; Chen MH; Wang YP; Chu CJ; Huang YH; Lin HC; Hou MC; Lee FY; Su TP; Lu CL
Gastroenterology; 2017 Jan; 152(1):134-141. PubMed ID: 27639806
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the risk of osteoporotic fractures with proton pump inhibitor use and histamine-2 receptor antagonist therapy in elderly women: A nationwide population-based nested case-control study.
Park JH; Song YM; Jung JH; Han K
Bone; 2020 Jun; 135():115306. PubMed ID: 32126312
[TBL] [Abstract][Full Text] [Related]
17. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
Park JH; Lee J; Yu SY; Jung JH; Han K; Kim DH; Rhee J
BMC Geriatr; 2020 Oct; 20(1):407. PubMed ID: 33059626
[TBL] [Abstract][Full Text] [Related]
18. Use of Proton Pump Inhibitors and Risk of Pancreatic Cancer: A Nationwide Case-Control Study Based on the French National Health Data System (SNDS).
Lassalle M; Le Tri T; Afchain P; Camus M; Kirchgesner J; Zureik M; Dray-Spira R
Cancer Epidemiol Biomarkers Prev; 2022 Mar; 31(3):662-669. PubMed ID: 34937794
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitor use and the risk for Parkinson's disease: A nationwide population-based study in Taiwan.
Chen HL; Lei WY; Wang JH; Bair MJ; Chen CL
Medicine (Baltimore); 2023 May; 102(19):e33711. PubMed ID: 37171333
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular comorbidities in patients with rosacea: A nationwide case-control study from Taiwan.
Hua TC; Chung PI; Chen YJ; Wu LC; Chen YD; Hwang CY; Chu SY; Chen CC; Lee DD; Chang YT; Liu HN
J Am Acad Dermatol; 2015 Aug; 73(2):249-54. PubMed ID: 26004520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]